Thermo Fisher kicked off 2025 with strong Q1 results, banking $10.36 billion in revenue and flexing its R&D muscles. CEO Marc ...

Goldman Sachs analyst Matthew Sykes lowered the firm’s price target on Thermo Fisher (TMO) to $610 from $670 but keeps a Buy rating on the ...

Life sciences company Thermo Fisher (NYSE:TMO) reported in Q1 CY2025, but sales were flat year on year at $10.36 billion. Its ...

Thermo Fisher CEO Marc Casper noted strong performance in Q1 2025, delivering $10.36 billion in revenue. Adjusted EPS grew 1% to $5.15. Adjusted operating income was $2.27 billion, with an adjusted ...

Thermo Fisher Scientific shares rose Wednesday after the lab equipment and life science solutions firm reported first-quarter ...

Thermo Fisher Scientific Inc. ( NYSE: TMO) Q1 2025 Earnings Conference Call April 23, 2025 8:30 AM ET Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President & Chief ...

Thermo Fisher Scientific reported better-than-expected profit and revenue for the first quarter on Wednesday, helped by ...

We recently published a list of 10 Best Stocks That Will Always Grow. In this article, we are going to take a look at where ...

Consensus $23.25. Expands FY25 revenue view to $43.3B-$44.2B from $43.5B-$44B, consensus $43.83B. Guidance taken from Q1 earnings conference ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

According to Research by SNS Insider, Global Prostate Cancer Diagnostics Market Growth is Fueled by Growing Demand for Advanced Biomarker Testing, AI Diagnostics, and Outpatient Screening Services ...